accountBoston Scientific Corp. yesterday said it has agreed to pay $296 million to settle a US Department of Justice investigation into charges that its Guidant heart-device subsidiary made faulty product reports...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Boston Scientific settles for $296m
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account